Proteomic Insights into Osteoporosis: Unraveling Diagnostic Markers of and Therapeutic Targets for the Metabolic Bone Disease
Biomolecules · 04.05.2024 · 14 (5) · 554
DOI: 10.3390/biom14050554 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 04.05.2024. Verfasst von Jihan Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Xi'an Key Laboratory of Stem Cell and Regenerative Medicine, Institute of Medical Research, Northwestern Polytechnical University, Xi'an 710072, Chin…. Hauptthemen laut MEDLINE: Proteomics, Osteoporosis, Biomarkers. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 169 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Open Funds for Shaanxi Provincial Key Laboratory of Infection and Immune Diseases, Shenzhen Science and Technology Program, Open Funds for Shaanxi Provincial Key Laboratory of Infection and Immune Diseases.
Abstract (Originalsprache)
Osteoporosis (OP), a prevalent skeletal disorder characterized by compromised bone strength and increased susceptibility to fractures, poses a significant public health concern. This review aims to provide a comprehensive analysis of the current state of research in the field, focusing on the application of proteomic techniques to elucidate diagnostic markers and therapeutic targets for OP. The integration of cutting-edge proteomic technologies has enabled the identification and quantification of proteins associated with bone metabolism, leading to a deeper understanding of the molecular mechanisms underlying OP. In this review, we systematically examine recent advancements in proteomic studies related to OP, emphasizing the identification of potential biomarkers for OP diagnosis and the discovery of novel therapeutic targets. Additionally, we discuss the challenges and future directions in the field, highlighting the potential impact of proteomic research in transforming the landscape of OP diagnosis and treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Xi'an Key Laboratory of Stem Cell and Regenerative Medicine, Institute of Medical Research, Northwestern Polytechnical University, Xi'an 710072, China.
- School of Medicine, Xi'an International University, Xi'an 710077, China.
- Department of Medical College, Hunan Polytechnic of Environment and Biology, Hengyang 421000, China.
- Research and Development Institute of Northwestern Polytechnical University in Shenzhen, Shenzhen 518057, China.
- School of Electronics and Information, Northwestern Polytechnical University, Xi'an 710129, China.
Förderung
- the Open Funds for Shaanxi Provincial Key Laboratory of Infection and Immune Diseases
- Shenzhen Science and Technology Program
- Open Funds for Shaanxi Provincial Key Laboratory of Infection and Immune Diseases
Zitieren
APA
Wang, J., Xue, M., Hu, Y., Li, J., Li, Z., & Wang, Y. (2024). Proteomic Insights into Osteoporosis: Unraveling Diagnostic Markers of and Therapeutic Targets for the Metabolic Bone Disease. Biomolecules, 14(5), 554. https://doi.org/10.3390/biom14050554
Vancouver
Wang J, Xue M, Hu Y, Li J, Li Z, Wang Y. Proteomic Insights into Osteoporosis: Unraveling Diagnostic Markers of and Therapeutic Targets for the Metabolic Bone Disease. Biomolecules. 2024;14(5):554. doi:10.3390/biom14050554
BibTeX
@article{Wang2024,
author = {Wang, Jihan and Xue, Mengju and Hu, Ya and Li, Jingwen and Li, Zhenzhen and Wang, Yangyang},
title = {Proteomic Insights into Osteoporosis: Unraveling Diagnostic Markers of and Therapeutic Targets for the Metabolic Bone Disease},
journal = {Biomolecules},
year = {2024},
volume = {14},
number = {5},
pages = {554},
doi = {10.3390/biom14050554}
}
EUVIMED